TCA
MDT icon

Transcend Capital Advisors’s Medtronic MDT Stock Holding History

Transcend Capital Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.97M Sell
22,752
-6,375
-22% -$611K 0.16% 128
2025
Q4 		$2.8M Sell
29,127
-797
-3% -$77.4K 0.22% 99
2025
Q3 		$2.85M Sell
29,924
-1,814
-6% -$167K 0.2% 107
2025
Q2 		$2.77M Sell
31,738
-28,606
-47% -$2.43M 0.21% 110
2025
Q1 		$5.42M Sell
60,344
-1,567
-3% -$140K 0.39% 52
2024
Q4 		$4.95M Sell
61,911
-9,644
-13% -$835K 0.36% 62
2024
Q3 		$6.44M Sell
71,555
-374
-0.5% -$31.5K 0.43% 52
2024
Q2 		$5.66M Buy
71,929
+2,219
+3% +$182K 0.41% 50
2024
Q1 		$6.08M Buy
69,710
+8,140
+13% +$695K 0.49% 41
2023
Q4 		$5.07M Buy
61,570
+3,304
+6% +$252K 0.45% 44
2023
Q3 		$4.57M Buy
58,266
+21,635
+59% +$1.81M 0.45% 46
2023
Q2 		$3.23M Sell
36,631
-784
-2% -$67.5K 0.31% 76
2023
Q1 		$3.02M Buy
37,415
+6,206
+20% +$506K 0.31% 78
2022
Q4 		$2.43M Sell
31,209
-5,829
-16% -$472K 0.26% 97
2022
Q3 		$2.99M Sell
37,038
-4,223
-10% -$380K 0.33% 75
2022
Q2 		$3.7M Sell
41,261
-9,827
-19% -$996K 0.39% 56
2022
Q1 		$5.67M Buy
51,088
+3,438
+7% +$363K 0.51% 39
2021
Q4 		$4.93M Buy
47,650
+4,621
+11% +$535K 0.44% 54
2021
Q3 		$5.34M Buy
+43,029
New +$5.57M 0.48% 43
2021
Q2 		– Sell
-43,295
Closed -$5.12M – 375
2021
Q1 		$5.12M Sell
43,295
-1,622
-4% -$190K 0.62% 31
2020
Q4 		$5.26M Buy
44,917
+10,553
+31% +$1.16M 0.69% 23
2020
Q3 		$3.57M Buy
34,364
+17,193
+100% +$1.73M 0.65% 36
2020
Q2 		$1.57M Sell
17,171
-1,461
-8% -$140K 0.51% 62
2020
Q1 		$1.69M Buy
18,632
+155
+0.8% +$16.5K 0.51% 57
2019
Q4 		$2.1M Buy
+18,477
New +$2.03M 0.56% 55

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Transcend Capital Advisors's MDT Position: Q1 2026 in Review

Transcend Capital Advisors reduced its Medtronic (MDT) stake by 22% in Q1 2026, selling an estimated $611K and leaving 22,752 shares worth $1.97M. The position accounts for 0.16% of the portfolio, ranked #128.

Transcend Capital Advisors first reported a position in MDT in Q4 2019 and has held it in 25 quarters since. The position peaked at $6.44M in Q3 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Transcend Capital Advisors held 22,752 shares of Medtronic worth $1.97M as of Q1 2026.
  • Transcend Capital Advisors sold 6,375 Medtronic shares in Q1 2026, an estimated $611K.
  • Medtronic made up 0.16% of Transcend Capital Advisors's portfolio in Q1 2026, its #128 holding.
  • Transcend Capital Advisors first reported a position in Medtronic in Q4 2019 and has held it in 25 quarters since.
  • Transcend Capital Advisors's Medtronic position peaked at $6.44M in Q3 2024.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Transcend Capital Advisors's 13F filing for Q1 2026, filed 13 May 2026.